Nimutan AB (publ)

Informe acción NGM:NIMU

Capitalización de mercado: kr15.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Nimutan Dirección

Dirección controles de criterios 2/4

Información clave

Ulrika Albers

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva4yrs

Actualizaciones recientes de la dirección

Recent updates

MedicaNatumin (NGM:MEDNA) Has Debt But No Earnings; Should You Worry?

Feb 16
MedicaNatumin (NGM:MEDNA) Has Debt But No Earnings; Should You Worry?

Estimating The Intrinsic Value Of MedicaNatumin AB (publ) (NGM:MEDNA)

Nov 03
Estimating The Intrinsic Value Of MedicaNatumin AB (publ) (NGM:MEDNA)

We Think MedicaNatumin (NGM:MEDNA) Has A Fair Chunk Of Debt

Aug 20
We Think MedicaNatumin (NGM:MEDNA) Has A Fair Chunk Of Debt

Does MedicaNatumin (NGM:MEDNA) Have A Healthy Balance Sheet?

Mar 23
Does MedicaNatumin (NGM:MEDNA) Have A Healthy Balance Sheet?

We Think MedicaNatumin (NGM:MEDNA) Has A Fair Chunk Of Debt

Dec 08
We Think MedicaNatumin (NGM:MEDNA) Has A Fair Chunk Of Debt

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Ulrika Albers en comparación con los beneficios de Nimutan?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2022n/an/a

kr24m

Mar 31 2022n/an/a

-kr6m

Dec 31 2021n/an/a

-kr8m

Sep 30 2021n/an/a

-kr18m

Jun 30 2021n/an/a

-kr20m

Mar 31 2021n/an/a

-kr8m

Dec 31 2020kr2mkr1m

-kr7m

Sep 30 2020n/an/a

-kr8m

Jun 30 2020n/an/a

-kr4m

Mar 31 2020n/an/a

kr898k

Dec 31 2019kr1mkr1m

kr526k

Sep 30 2019n/an/a

kr12m

Jun 30 2019n/an/a

kr14m

Mar 31 2019n/an/a

kr19m

Dec 31 2018kr1mkr965k

kr27m

Compensación vs. Mercado: Insufficient data to establish whether Ulrika's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensación vs. Ingresos: Ulrika's compensation has been consistent with company performance over the past year.


CEO

Ulrika Albers (54 yo)

less than a year

Permanencia

kr1,810,000

Compensación

Ms. Ulrika Albers serves as Chief Executive Officer and President of MedicaNatumin AB (publ) since October 2022 and served as its Chief Executive Officer and President since 2018.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Anna Stalenbring
Director3yrskr91.00ksin datos
Ulf Bjorklund
Director4yrskr163.00ksin datos
Lars Karnerud
Vice Chairman of the Board7yrskr309.00ksin datos
Bengt Johansson
Director6yrskr670.00ksin datos
Jonas Carpvik
Chairman of the Board3yrskr213.00ksin datos

4.0yrs

Permanencia media

66yo

Promedio de edad

Junta con experiencia: NIMU's board of directors are considered experienced (4 years average tenure).